METSERA
LIVE

Serial Number

98885164

Owner

Metsera, Inc.

Attorney

Andrea Christensen

Filing Date

Dec 4, 2024

Add to watchlist:

No watchlists yet
View on USPTO

METSERA Trademark

Serial Number: 98885164

METSERA is a trademark filed by Metsera, Inc. on December 4, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Metsera, Inc. (3 trademarks)

1200 Morris Turnpike, Suite 3005
Short Hills, NJ 07078

Entity Type: 03

Trademark Details

Filing Date

December 4, 2024

Registration Date

Not Registered

Published for Opposition

July 1, 2025

Goods & Services

Data collection and analysis of quality metric data services for business purposes in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; business consulting and business analysis services relating to information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications

Providing administration of health care plans, namely, providing insurance verification and prior authorization services for others; financial administration of patient reimbursement programs

Computer programming consultancy; Computer software consulting; Advanced product research in the field of artificial intelligence; Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare access to a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeys, pathways, and care programs; computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, lab data, care demographics, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; Scientific and technological services, namely scientific research and analysis in the fields of medicine, health and wellness; design and development of computer hardware and computer software; biomedical research; computer software development; scientific laboratory services; provision of information relating to medical and scientific research in the field of pharmaceutical products; computer software programming for others; all of the foregoing services provided in the fields of medicine, health, fitness, exercise and wellness

House mark for a full line of pharmaceuticals; pharmaceutical preparations for the treatment of metabolic conditions

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 14, 2026 EXRA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 20, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 20, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 20, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 20, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 20, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 20, 2026 COAR
SOU EXTENSION 1 GRANTED
Feb 4, 2026 EX1G
SOU EXTENSION 1 FILED
Feb 4, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 4, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 26, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 25, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 27, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
May 27, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 27, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
May 27, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 27, 2025 CNEA
ASSIGNED TO EXAMINER
May 23, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2025 NWOS
NEW APPLICATION ENTERED
Dec 4, 2024 NWAP